Clinical Trials Logo

Jaw, Edentulous, Partially clinical trials

View clinical trials related to Jaw, Edentulous, Partially.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06294249 Completed - Clinical trials for Jaw, Edentulous, Partially

Pain Severity in Flapless Dental Implant Placement Using Laser

Start date: January 1, 2020
Phase: Phase 4
Study type: Interventional

The goal of this split-mouth randomized clinical trial study was to investigate the effect of using a laser on pain and discomfort following flapless dental implant surgery. It was hypothesized that laser did not have any impact on post-op pain. Therefore, the study aimed to compare pain and discomfort following flapless dental implant surgeries with or without a laser.

NCT ID: NCT04271423 Completed - Clinical trials for Jaw, Edentulous, Partially

Ridge Preservation Comparing a Flap Versus Flapless Technique

Start date: April 2006
Phase: N/A
Study type: Interventional

To compare a flapless technique of alveolar ridge preservation to a flap technique to determine if preserving the periosteal blood supply would prevent loss of crestal ridge width and height.

NCT ID: NCT04017026 Completed - Clinical trials for Dental Implant Failed

Survival and Success Rates of 6mm Implants With a Micro-rough Surface After 4.5 - 18.2 Years in Function

Start date: May 9, 2018
Phase:
Study type: Observational

In this retrospective study, approximately 60 patients treated with 6mm short implants (Straumann, SLA (sandblasted, large-grit, acid-etched surface), SLActive (sandblasted, large-grit, acid-etched, hydrophilic surface), 4.1 or 4.8 mm in diameter) will be followed for 4.5-18.2 years. Clinical and radiographic parameters will be assessed in a follow-up examination.

NCT ID: NCT03812276 Completed - Clinical trials for Jaw, Edentulous, Partially

Neodent Implantable Devices of GM Line

Start date: February 14, 2019
Phase:
Study type: Observational [Patient Registry]

Acqua GM (Grand Morse) Helix implants present an optimized implant design with adapted treatment protocol, allowing for treatment of patients with different bone qualities. The objective of the study is to prospectively collect clinical data to confirm the long-term safety and clinical performance of Acqua GM Helix implants and GM prosthetic abutments in daily dental practice setting, by means of success and survival rates of these devices. Devices will be used according to standard routine in daily practice, according to all indications as specified by the manufacturer in the IFU (instructions for use). patients will be followed for 36 months after implant placement.

NCT ID: NCT03496688 Completed - Clinical trials for Jaw, Edentulous, Partially

Comparative Results of Six Biomaterials Used in Two-stage Maxillary Sinus

Start date: January 12, 2015
Phase: N/A
Study type: Interventional

Objectives: The aim of the study was to compare histological and histomorphometric results of six bone substitute materials used as graft in two-stage maxillary sinus augmentation model, after 6-month-healing.

NCT ID: NCT03252106 Completed - Clinical trials for Jaw, Edentulous, Partially

Long-term Effectiveness of Contour Augmentation in Sites With Early Implant Placement

Start date: October 10, 2016
Phase: N/A
Study type: Interventional

In this prospective case series study, 20 patients with an implant-borne single crown following early implant placement with simultaneous contour augmentation will be followed for 10 years. Clinical, radiologic, and esthetic parameters will be assessed. In addition, cone beam computed tomography (CBCT) will be used at 10 years to examine the facial bone wall and compared to the 6 year data.

NCT ID: NCT03059108 Completed - Clinical trials for Jaw, Edentulous, Partially

Evaluation of B+ Surface on Early Loading

Start date: February 20, 2017
Phase: N/A
Study type: Interventional

The trial is designed as a consecutive enrollment prospective one-center study. A minimum of 30 patients will be included in the study. At implant installation, the implant will be randomized to one of the groups (Control: conventional loading, 8 weeks; Test: early loading, 4 weeks). Samples of peri-implant crevicular fluid (PICF) and intrasulcular plaque will be collected at -14, 0 (Baseline: prosthesis delivery), 7 days and 1, 3, 6, 12 months. Prosthesis will be fabricated and delivered as usual, i.e., approximately two weeks after the impressions are taken.

NCT ID: NCT02975674 Completed - Clinical trials for Jaw, Edentulous, Partially

Evaluation of MT-12 Implant Survival and Marginal Bone Loss

213CEIH2016
Start date: November 2016
Phase: N/A
Study type: Interventional

The trial is designed as a consecutive enrollment prospective one-center study. A minimum of 30 patients will be included in the study. At implant installation, the patient will be randomized to receive one of the two types of implants (Control: internal hexagon connection implants (CON.INT); Test: Morse taper connection implants (MT-12)). Samples of peri-implant crevicular fluid (PICF) and intrasulcular plaque will be collected at -21 (second-stage surgery), -14 (impressions), 0 (Baseline: prosthesis delivery), 7 days and 1, 3, 6, 12 months. Prosthesis will be fabricated and delivered as usual, i.e., approximately two weeks after the impressions are taken.

NCT ID: NCT02798887 Completed - Clinical trials for Jaw, Edentulous, Partially

Ridge Preservation Comparing the Healing With or Without a Barrier Membrane

Start date: August 24, 2016
Phase: N/A
Study type: Interventional

Ridge Preservation Comparing the Clinical and Histologic Healing of Membrane vs. no Membrane Approach to Grafting.

NCT ID: NCT02487758 Completed - Clinical trials for Jaw, Edentulous, Partially

Ridge Preservation Comparing the Clinical and Histologic Healing of Flap vs. Flapless Approach to Grafting

Start date: August 2015
Phase: N/A
Study type: Interventional

Ridge Preservation Comparing the Clinical and Histologic Healing of Flap vs. Flapless Approach to Grafting